Objective: Repairing articular cartilage is clinically challenging. We investigated a simple, effective and clinically feasible cell-based therapeutic approach using a poly(lactide-co-glycolide) (PLGA) scaffold seeded with autologous endothelial progenitor cells (EPC) to repair a full-thickness osteochondral defect in rabbits using a one-step surgery. Methods: EPC obtained by purifying a small amount of peripheral blood from rabbits were seeded into a highly porous, biocompatible PLGA scaffold, namely, EPC-PLGA, and implanted into the osteochondral defect in the medial femoral condyle. Twenty two rabbits were randomized into one of three groups: the empty defect group (ED), the PLGA-only group or the EPC-PLGA group. The defect sites were evaluated 4 and 12 weeks after implantation. Results: At the end of testing, only the EPC-PLGA group showed the development of new cartilage tissue with a smooth, transparent and integrated articular surface. Moreover, histological analysis showed obvious differences in cartilage regeneration. At week 4, the EPC-PLGA group showed considerably higher TGF-b2 and TGF-b3 expression, a greater amount of synthesized glycosaminoglycan (GAG) content, and a higher degree of osteochondral angiogenesis in repaired tissues. At week 12, the EPC-PLGA group showed enhanced hyaline cartilage regeneration with a normal columnar chondrocyte arrangement, higher SOX9 expression, and greater GAG and collagen type II (COLII) content. Moreover, the EPC-PLGA group showed organized osteochondral integration, the formation of vessel-rich tubercular bone and significantly higher bone volume per tissue volume and trabecular thickness (Tb.Th). Conclusion: The present EPC-PLGA cell delivery system generates a suitable in situ microenvironment for osteochondral regeneration without the supplement of exogenous growth factors.
Introduction
Damaged articular cartilage has poor self-repairing capabilities using regenerating hyaline cartilage. Chondrocytes, the cells responsible for hyaline cartilage regeneration, are confined to the extracellular matrix (ECM), and the transport of nutrients and growth factors to and from the cartilage is primarily through the synovial fluid; also, nutritional supply may be through the subchondral bone as a second way 1, 2 . Among the cartilage lesions, osteochondritis dissecans (OCD) occur most frequently in the knee due to a full-thickness defect in the hyaline cartilage and underlying bone tissue 3 . The current therapeutic options for an osteochondral defect include microfracture surgery, autologous chondrocyte implantation (ACI) and osteochondral transplantation (OCT) 4e6 . Microfracture surgery is usually used for small focal cartilage defects (<2 cm 2 ) by stimulating the surrounding bone marrow-derived mesenchymal stem cells (BMSC) to generate new cartilage tissue 7 . However, this newly formed cartilage is mostly fibrocartilage. ACI or OCT derived from self-donor is another further choice for osteochondral lesions 8 . ACI is limited by high costs and time-demanding procedures involving the isolation and expansion of cells (up to 3e4 weeks). ACI also carries a higher risk of contamination and severe postoperative pain caused by the twostep surgery. Moreover, it also often results in fibrocartilage growth 9 . Disadvantages of OCT include the limited morbidity of the injured site, a shortage of donors, and the poor integration of the host's tissue in the patient 10 . Taken together, there is still a lack of a standard treatment protocol for cartilage injuries. Recently, the application of therapeutic cell engineering with scaffolding substitutes has become a promising treatment strategy for osteochondral repair. We have previously demonstrated that a degradable porous poly(lactide-co-glycolide) (PLGA) scaffold created a temporary space for neo-tissue development and facilitated the regeneration process of cartilage defects 11e13 . PLGA has been used as a biomaterial in FDA-approved medical devices, in orthopedic applications and extensively in pre-clinical trials 14e16 .
Clinically, autologous cells, such as BMSC, are commonly used in cell-based therapies with a minimal immune response. BMSC have been used in some in vivo studies 17, 18 and in clinical trials of osteochondral repair 19, 20 . However, BMSC commonly require a prolonged period in specific culture conditions (i.e., supplemental growth factors) before they can differentiate into chondrocytes, which are essential for the formation of hyaline cartilage.
Since endothelial progenitor cells (EPC) were first discovered in 1997, evidence has continued to accumulate that EPC provide a high capacity for regeneration and vasculogenesis in different tissues via direct cell fusion and indirect paracrine mechanisms. Circulating EPC are often adopted and cultured in medium favoring endothelial differentiation, in which isolation could dispel donor site morbidity risks and hence provide an ideal autologous cell source for further therapies. Therapeutic applications for EPC have been reported for cardiovascular diseases 21, 22 and bone regeneration 23e25 . However, no previous studies have evaluated the effect of EPC in cartilage repair.
Accordingly, we hypothesized that a porous PLGA scaffold can provide a degradable structure and a topographical cue to promote cell migration, attachment, proliferation, and tissue regeneration. Meanwhile, EPC will offer a biological cue and change in situ the microenvironment or niche, which will trigger the surrounding therapeutic stem cells to commence self-renewal, proliferation, differentiation, and mobilization, and aid chondrogenesis, osteogenesis 25, 26 and angiogenesis 27, 28 , thereby remedying osteochondral defects. The combined effects could help achieve osteochondral repair without the supplement of exogenous growth factors.
Methods

Isolation of EPC
Peripheral blood was obtained from New Zealand White rabbits via the peripheral ear artery (10 ml/kg). Peripheral blood mononuclear cells were isolated by density gradient centrifugation with Ficoll-Plaque Plus (Amersham Biosciences). Subsequently, mononuclear cells were washed and then incubated on culture dishes that were coated with fibronectin and supplied with endothelial growth medium (EGM)-2 (Cambrex Corp). After 7 days of incubation, the adherent cells (early EPC) were harvested by trypsinization for analysis or transplantation. The EPC isolated from rabbits were also characterized and confirmed as previously described 22 .
Briefly, cells were incubated with acetyl-LDL (10 mg/ml; Molecular Probes, Carlsbad, CA) and isolectin (5 mg/ml; Molecular Probes). The staining of acetyl-LDL and isolectin in cultured EPC was detected under fluorescence confocal microscopy at absorption wavelengths of 555 and 495 nm, respectively. In addition, the expression of Flk-1 (a specific endothelial cell marker; Santa Cruz Biotechnology, Santa
Cruz, CA) after processing indirect immunofluorescence (IF) staining was analyzed by confocal microscopy.
Preparation of porous PLGA and EPC-PLGA scaffolds
A porous PLGA (lactide/glycolide ratio of 85/15, molecular weight 50e75 kDa) scaffold with a compressive modulus of 0.65 AE 0.11 MPa, pore size of 395.27 AE 11.65 mm, and porosity over 90% was fabricated via the salt-leaching technique, as described in our prior work 12 . In brief, 4 ml of 20% w/v PLGA chloroform solution was first mixed with 7.2 g of sodium chloride. This mixture was poured into cylindrical molds and lyophilized for 1 day to form the PLGA sponges. The cylindrical sponges were then immersed in deionized water to dissolve the porogen. The sponges were cut into cylinders of 3 mm in height and 3 mm in diameter. After 7 days of incubation, adherent autologous EPC were trypsinized, centrifuged, resuspended in medium at a concentration of approximately 5.0 Â 10 5 cells/mL, and seeded into PLGA scaffolds using a 0.43-mm syringe for 3-D cultures. The cultures were maintained in 24-well culture plates for 4 h, and fresh medium was supplied before incubation for 1 day at 37 C in a 5% CO 2 environment. Before the delivery of the autologous cell-seeded scaffolds to animals, the attachment of EPC onto the PLGA (EPC-PLGA) scaffolds was confirmed using a scanning electron microscope, and the attachment ratio was calculated. The harvested EPC were labeled with cell tracker (CM-DiI, Molecular Probes) 29 immediately before transplantation to trace the fate of these cells.
Assessment of EPC attachment and viability in vitro
EPC were stained by trypan blue, and an automated cell counter (Countess Ò , Invitrogen) was used to determine the differences between the numbers of seeded and floating cells after 1 day. The bottoms of the 24-well culture plates were initially covered with PVC to prevent cell attachment and offset of the errors. Cell viability was assessed using a standard MTS-based assay (Promega) 11 to evaluate the number of viable adherent cells on scaffolds by mitochondrial succinate dehydrogenase activity. Quantitative data for the absorbance values were obtained at a wavelength of 490 nm via an ELISA reader (Sunrise, Tecan). The scanning electron microscope (LV-SEM, JSM-6390LM) image shows cells attached morphologically onto the PLGA scaffolds. The dehydrated samples were sputter coated with a thin layer of gold and imaged by SEM at an acceleration voltage of 20 keV.
Transplantation of EPC-seeded PLGA scaffolds in rabbits
All experimental animal procedures were approved by the Animal Care and Use Committee of National Cheng Kung University and performed in accordance with strictly aseptic techniques. An osteochondral defect model was established, as described in our previous study 12 . Briefly, 22 4-to 5-month-old New Zealand White male rabbits (Livestock Research Institute, Taiwan), weighing 2e 3 kg, were used in the study, providing 44 knees. Anesthesia was induced by a subcutaneous injection of Zoletil 50 (25 mg/kg) and maintained with a volatile halation of isoflurane (2% v/v in oxygen). Following anesthesia, both legs were shaved, brushed, disinfected with ethanol-iodine, and covered with an aseptic drape. The knee was exposed by an anteromedial parapatellar longitudinal incision and a capsular incision. To limit the amount of spontaneous healing, full-thickness cartilage defects (3 mm in diameter and 3 mm in depth) were created on the weight-bearing zone of the medial femoral condyle 30 . The full-thickness defect was created using an electric drill, and the joint was irrigated immediately with sterile isotonic saline. After removing the debris from the defect, the rabbits were randomly distributed into one of three treatment groups: the empty defect (ED) group, the PLGA group or the EPC-PLGA group. In the EPC-PLGA and PLGA-only groups, PLGA scaffolds were gently inserted and press fit into the defect hole and then flushed with normal saline. The patella was repositioned, and the wound was closed in layers. After the surgical procedure, the rabbits were housed singly and allowed free cage activity with unrestricted weight-bearing activity. Enrofloxacin (25 mg/kg) and an analgesic (Ketoprofene) were administered subcutaneously for 3 days. A neck collar was applied to prevent the animals from biting the wound. The rabbits were euthanized 4 or 12 weeks after the operation with an intravenous injection of 120 mg/kg pentobarbital. Overall, there were eight knees in the EPC-PLGA group, and six knees in each of the ED and PLGA-only groups at each experimented time point (Supplementary Data S1). Each distal femur was harvested for further examinations.
Macroscopic evaluations
After postoperative euthanasia at 4 weeks (ED and PLGA groups: six knees each; EPC-PLGA group: eight knees; Sham: four knees) and 12 weeks (ED and PLGA groups: six knees for each; EPC-PLGA group: eight knees), the macroscopic scores of the reparative tissue were blindly assessed by two researchers based on our previous scoring system 12 , which assesses coverage, tissue color, and surface condition. The maximum total score is 12 points (Supplementary Data S2).
Micro-CT evaluations
To individually evaluate qualitative and quantitative measurements of the bone regeneration level within the defects, medial femoral condyles in the ED and PLGA groups were scanned using a microtomograph 1076 scanner (Skyscan). The ED (six knees), PLGA (six knees), EPC-PLGA (eight knees) groups were analyzed at each time point in comparison with the sham group (four knees). The formalin-fixed rabbit femur ends were loaded on a sample holder with the femur axis perpendicular to the scanning plane. Regarding the parameters of the X-ray source presenting mineralized tissue, the voltage was set to 50 kV, and the current was set to 160 mA
.
The samples were scanned through a 360 rotation angle with a rotation interval of 1 and a pixel size with 18-mm resolution. The Skyscan software package was used to analyze the image data and visualize the new bony matrix. From the CT data set, a cylindrical region of interest (ROI) 3 mm in diameter within the repaired site, which corresponds to the original defect region, was selected for analysis. The volume and diameter of the bone growth were measured as bone volume per tissue volume (BV/TV) and trabecular thickness (Tb.Th), respectively.
Staining, histology, scores, and immunostaining
For histological sections, all samples were prepared by the ChiMei Medical Center Department of Pathology. The samples were treated in accordance with standard processing, which incorporates 10% formalin fixation, gradient dehydration in ethanol dilutions, decalcification, infiltration and paraffin embedding. The samples were cut into four-micron-thick sections and stained with hematoxylin and eosin (H&E) to assess the cell morphology and inflammatory responses, Masson's trichrome to assess the overall collagen syntheses and alignment, and Alcain blue to assess the glycosaminoglycan (GAG) content. The samples were observed using a microscope (Olympus BX51). The images of the sections were recorded using a digital CCD (Olympus DP70). Moreover, to determine the content of collagen type I (COLI) (fibrocartilage) & II (hyaline cartilage), SOX9 (chondrocyte), CD31 and the Von Willebrand factor (vWF, an endothelial marker) in the regenerated tissues, the sections were evaluated by either immunohistochemistry (IHC) or IF analysis. All primary antibodies were 1:100 dilutions. All staining protocols followed the manufacturers' recommended guidelines. For IHC analysis, we used the rabbit/mouse HRP/DAB polymer detection (BioSB) kit. For IF analysis, we used the FITC-and Rhodamine RedÔ-conjugated goat antiemouse IgG antibody kit (Jackson ImmunoResearch Laboratory). The histological scores of the regenerated tissue were assessed blindly by two investigators according to our previous study 12 . The main categories of the histological scores include the overall filling assessment, bone filling, subchondral morphology, bonding to bone surface morphology, cartilage thickness, surface regularity, chondrocyte clustering, neosurface GAG&Cell content, and adjacent surface GAG&Cell content. Furthermore, we evaluated PLGA degradation after implantation (Supplementary Data S3). Moreover, vascular density was determined by the number of vessels per area of each histology image under 200Â magnification.
Statistical analysis
All of the data are shown as the mean AE 95% confidence intervals (CI). Statistical analyses were performed using the SPSS v17.0 software package. Due to the concern of outcome dependence by using bilateral knees of animal in individual group 31 , gross appearance scores, histology scores, and quantitative micro-CT data were thus analyzed using generalized estimating equations (GEE) model 32 at each time point. A significant difference was accepted when P < 0.05.
Results
Evaluations of autologous EPC onto PLGA
We have previously characterized the phenotyping and genotyping of cultured rabbit EPC 22 . These cells uptake acetyl-LDL and isolectin and express Flk-1 on the cell membrane. Most important, the early EPC outgrow and form monolayer colonies with "cobblestone" morphology after culturing in EGM-2 for 7 days (Fig. 1 ). These EPC were subsequently harvested and then inoculated in 3-D PLGA scaffolds for 24 h. The inoculated cells attached, spread, and surrounded the inner and outer surface of the porous scaffolds (Fig. 1) . The overall cell attachment ratio was approximately 78 AE 2.7% after 24 h of incubation, which was in line with the absorbance of EPC using the MTS-based assay (the absorbance value was 0.27 AE 0.01 for EPC-seeded scaffolds and 0.04 AE 0.01 for scaffolds without cell seeding). Furthermore, fluorescence-labeled EPC were detected in the implanted site after 2 weeks, indicating the successful homing and retention of the transplanted cells in the PLGA scaffolds (Supplementary Data S4).
Tissue regeneration in rabbit osteochondral defects
The osteochondral regenerative response of autologous EPCseeded PLGA scaffolds under in situ physiological conditions was determined by the creation of a full-thickness osteochondral defect in the high weight-bearing zone of the medial condyle in rabbits using a one-step surgery (Fig. 2) .
weeks after implantation
The functional activities of all animals were recovered within 4 weeks after the implantations, and no infections or surgical complications, such as stiff joints or contractures, were recorded. Regarding gross appearance, the EPC-PLGA group showed a more obvious whitish fibrous tissue growing toward the center of the defect, whereas the borders between the defect and the surrounding cartilage were distinct in the ED and PLGA-only groups, suggesting a poor integration of the regenerating and native cartilages in the ED and PLGA-only groups [ Fig. 3(a) ]. In addition, the gross appearance scores were significantly higher in the EPC-PLGA group than in the ED (P < 0.001) and PLGA-only groups (P < 0.001) [ Fig. 3(b) ].
Light microscopy showed that the osteochondral regeneration in the EPC-PLGA group was characterized by visible chondroblasts and immature chondrocytes and a greater amount of hyaline-like cartilage tissues in the reparative defect region. Histological stainings confirmed more GAG, osteoid matrix, and the formation of compact bone and the presence of osteoblasts in these sites (Fig. 4) . In contrast, in the PLGA-only and ED groups, the defects were filled with misaligned fibrous tissues or poorly repaired tissues, including predominantly fibroblast-like cells with different degrees of stromal hyalinization (Fig. 4) . The formation of neovasculature with CD31þ/vWFþ endothelial cell lining was detected at the central regions of the EPC-PLGA grafts [ Fig. 5(a) ], while only very limited angiogenesis was observed in the PLGA-only and ED groups. On the other hand, the central regions of the osteochondral defect in the non-EPC-treated animals were hemorrhagic and loaded with edematous vesicles [ Fig. 5(a) ]. Quantitative measurements confirmed that the vascular density was significantly higher in the EPC-PLGA group (23.4 AE 8.78) than in the ED (5.17 AE 2.23) and PLGA-only groups (10.17 AE 2.93) (P < 0.001 and P ¼ 0.001, resp) [ Fig. 5(b) ]. Furthermore, the matrix in the EPC-PLGA group contained a considerable amount of ECM, COLI and collagen type II (COLII) by immunostaining. The two critical endogenous growth factors for osteochondral regeneration, namely, TGF-b2 and TGF-b3, were also highly expressed in these sites 4 weeks after implantation (Fig. 6 ).
Based on these changes during the early stage of regeneration, we examined the osteochondral regeneration effects of EPC-PLGA scaffolds 12 weeks after implantation. Surprisingly, the gross appearance of the regenerated osteochondral defects in the EPC-PLGA group showed newly grown cartilage tissue appearing in a smooth, transparent and shiny articular surface that was not distinguishable from the host cartilage tissue, indicating excellent integration of the regenerated tissue and the neighboring cartilage [ Fig. 3(a) ]. On the other hand, the PLGA-only and ED groups had opaque tissues and osteoarthritic changes on the degenerative articular surface [ Fig. 3(a) ], which is consistent with our previous study 12 . Qualitative scores of the defect in the EPC-PLGA group (10.38 AE 0.32) were significantly higher than those in the ED (5.71 AE 0.99) and PLGA-only (7.5 AE 1.01) groups (P < 0.001 and P ¼ 0.001, respectively), indicating superior osteochondral regeneration [ Fig. 3(b) ]. Histological examination further confirmed that the EPC-PLGA group showed the construction of nearly native hyaline cartilage that appeared in a normal columnar chondrocyte arrangement with the expression of SOX9 and abundant GAG and COLII content (Fig. 6 ). The regenerated tissues completely integrated with the adjacent cartilage and bone. Furthermore, increased neovascularization was indicated by the formation of CD31þ and vWFþ endothelial cell lining at these sites [ Fig. 5(c) ]. In contrast, the PLGAonly group exhibited mainly fibrocartilaginous mixing with a modest amount of GAG content (Fig. 4) . The ED group displayed fibrous tissues with cell disarrangement and less GAG content within the defect and depletion at the integration sites (Fig. 4) . The total histological scores were significantly higher in the EPC-PLGA group than in the ED and PLGA-only groups at week 12 (Table I) ; in particular, the scores for surface morphology, cartilage thickness and GAG content were remarkably higher in the EPC-PLGA group than in the ED and PLGA-only groups (Supplementary Data S5). Fig. 2 . The schematic representative images of the one-step surgery of full-thickness osteochondral defects in the high weight-bearing zone of medial condyle of the rabbits. 
Bone regeneration
In the present study, a micro-CT system was used to assess the quality and quantity of bone regeneration. At week 4, neo-osseous tissue was regenerated from the edge toward the central region of the defect site in all groups [ Fig. 7(a) ]. The formation of osteoid matrix surrounded by osteoblasts within the pores of PLGA scaffolds was observed in the ED-PLGA group [ Fig. 7(d The qualitative gross appearance score was significantly higher in the EPC-PLGA group than in the ED and PLGA-only groups. Fig. 4 . The histological examinations of the ED, PLGA and EPC-PLGA groups 4 and 12 weeks after implantation. The sections were stained by Masson's trichrome to assess the overall collagen syntheses and alignment, H&E to assess the cell morphology, and Alcian blue staining to assess the GAG content. At week 4, the EPC-PLGA group showed a greater number of chondroblasts, greater GAG content, and the formation of osteoid matrix; however, the ED and PLGA-only groups showed poor fibrous tissues with predominantly fibroblast-like cells. At week 12, the EPC-PLGA group showed enhanced hyaline cartilage regeneration with a sound columnar chondrocyte arrangement and abundant GAG content in the adjacent remodeled and native cartilaginous tissues. In contrast, the ED and PLGA-only groups showed only modest GAG content in the defect sites. In addition, the PLGA-only group exhibited mainly fibrocartilaginous tissue, and the ED group displayed fibrous tissues with cell de-arrangement. Square denotes magnification scale. Arrow shows the border of the repaired tissue. On the other hand, the central regions of the osteochondral defects in the non-EPC-treated animals were hemorrhagic (H) and contained edematous vesicles (Ev). In addition, scaffolds (Sc) were endocytosed by giant cells (Gc). (b)Vascular density was significantly higher in the EPC-PLGA group than in the ED and PLGA-only groups. (c) 12 weeks after the operation, significantly more mature vascular structures were generated in the repaired site with the presence of CD31þ and vWFþ cell lining. *: compared with the ED group at (P < 0.05); #: compared with the PLGA group (P < 0.01). Fig. 6 . Specific proteins within defect sites were detected by IHC staining. 4 weeks after implantation, the matrix in the EPC-PLGA group expressed a considerable amount of ECM, COLI and COLII. TGF-b2 and TGF-b3 were also highly expressed at these sites. 12 weeks after implantation, the EPC-PLGA group contained nearly native hyaline cartilage with a normal columnar chondrocyte arrangement and expressed higher levels of SOX9 and an abundance of GAG and COLII. Dash line indicates integration between host and regenerative tissues.
Discussion
In the present study, we demonstrated that the transplantation of EPC seeded in 3D PLGA grafts enhances the formation of hyaline cartilage and the neovascularization in the subchondral bone of osteochondral defects. Most important, we present the first study supporting that modulation of the in situ microenvironments for the functional remodeling of osteochondral defects by increasing the formation of neo-hyaline cartilage and the growth of columnar rounded chondrocytes with enriched synthesis of collagen II and GAG. Furthermore, we highlight that this cell-based therapeutic approach was achieved without the supplement of exogenous growth factors.
Despite the advances in conventional surgical techniques in articular cartilage repair, the formation of fibrocartilage tissues in the replacement of hyaline cartilage eventually leads to the development of osteoarthritis in the defect joints. Recent progress in osteochondral regeneration has focused on (1) autologous cell origin for minimal immune responses, (2) engineered scaffolding substitutes in providing a provisional space for effective tissue regeneration, and (3) the manipulation of appropriate bioenvironments for cell proliferation and differentiation. Therefore, it is essential to develop an autologous cell-based therapy in combination with a biocompatible scaffold system to generate a suitable microenvironment for osteochondral regeneration. y Compared with the ED group at the same time point (P < 0.01).
z Compared with the PLGA group at the same time point (P < 0.01). Clinically, the implantation of autologous chondrocytes is technically challenging and expensive, requires longer isolation and culturing times and two-step surgery, and, most undesirably, enables the formation of fibrocartilage. BMSCs have been attractive therapeutic candidates for orthopedic applications. However, the isolation of BMSCs usually requires painful surgical interventions and supplementary growth factors for cell differentiation.
PLGA scaffolds with proper pore sizes serve as a suitable matrix that provides an attached biocompatible environment for EPC (Fig. 1) . These scaffolds provide a mechanical support for stem cells and serve as a 3D topographical cue for stem cell migration, attachment and homing at the site of the defect. Apart from direct cell fusion, the release of bioactive growth factors or cytokines stimulates cell proliferation and directs cell differentiation into the specialized cells or tissues. Therefore, our delivery system incorporating EPC with PLGA scaffolds theoretically provides a biological cue to recruit surrounding cells and offers a vessel-rich microenvironment for nutrition support in the regenerating joint tissue (Figs. 4e6) . In comparison to the placebo and the PLGA-only treatment groups, the EPC-PLGA complex generated a considerably higher amount of ECM and collagen I/II in the defect joints. To further characterize this phenomenon, we determined the levels of two critical growth factors for osteochondral regeneration in the tissues, namely, TGF-b2 and TGF-b3. The TGF-b superfamily regulates several important down-stream molecules in the control of cell proliferation, differentiation, and tissue regeneration 33 . TGF-b2 and TGF-b3 have been demonstrated to mediate important responses in cartilage and bone regeneration in vitro 34, 35 and in vivo 36, 37 . In line with these previous reports, we found that knees implanted with EPC-PLGA expressed considerably high tissue levels of TGF-b2 and TGF-b3 in the repaired sites (Fig. 6) . Furthermore, more GAG was synthesized in the adjacent remodeled and native cartilaginous tissues, whereas the ED and PLGA-only groups showed only modest GAG content in the defect sites (Fig. 4) . Using the Alcian blue stain, we confirmed the presence of new chondrocytes within the cartilaginous areas of the spongiosal bone, or so-called primary spongiosa, in the deep region of the grafting site (Fig. 4) . This phenomenon reveals that trabeculae are present in the calcified cartilage core until all the trabeculae are eroded from their surfaces and removed by osteoclasts 38 . Therefore, the transplantation of EPC in the PLGA scaffolds appeared to direct the regenerative process in the osteochondral defects by generating hyaline cartilage, while the ED and PLGA-only groups showed the formation of mainly fibrous or fibrocartilage tissues. These molecular and histological changes (Figs. 4 and 6) are consistent with the findings under micro-CT examination (Fig. 7) , which showed that EPC-PLGA treatment provided significantly higher bone matrix and structurally adequate primary biomechanical stability in the repaired cartilage. The mechanical recovery of healing cartilage correlates with the subchondral bone regeneration 39 . Our present study design did not provide direct evidence for the final fate of the transplanted EPC, as these endothelial progenitors may transdifferentiate into other mesenchymal cells, i.e., chondrocytes. Nevertheless, this cell-and scaffold-based tissue engineering approach is the first study demonstrating that highly angiogenetic EPC provide benefits in hyaline cartilage regeneration associated with sound underlying bone regeneration in osteochondral defects. To our knowledge, only one previous study has suggested that endothelial cells transdifferentiate into mature chondrocytes and osteocytes through the endothelial-tomesenchymal transition in an experimental model of fibrodysplasia ossificans progressive 40 . However, the limitation of present study is that the direct mechanisms underlying the role of EPC in cartilage repair and their interaction with surrounding tissues remain unknown and need to be addressed in future research.
In conclusion, we demonstrated that pre-seeding EPC onto highly porous, biocompatible PLGA scaffolds creates a favorable in situ microenvironment for the regeneration of osteochondral regions by facilitating chondrocyte growth and hyaline cartilage synthesis and providing sound, complete osteochondral integration and a vascularized bone matrix. As opposed to traditional therapies, this implantation scaffold also provides a simple, effective, and clinically feasible cell transplantation system to enable the generation of hyaline cartilage and bone tissue regeneration without the supplement of exogenous growth factors.
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